Study Material | Test Series
Drishti IAS
call1800-121-6260 / 011-47532596
Drishti The Vision Foundation
(A unit of VDK Eduventures Pvt. Ltd.)
Rotavac Launched for Rotavirus Protection
Mar 12, 2015

The Prime Minister, Narendra Modi launched the first indigenously developed and manufactured Rotavirus vaccine—Rotavac—on 9th March. Each year, diarrhoea caused by rotavirus results up to 10 lakh hospitalizations and kills nearly 80 thousand children under the age of 5 years. Besides causing emotional stress to the affected families, it also pushes many Indian families below the poverty line and also imposes significant economic burden on the country. 

 

Salient Features

  • The first indigenous rotavirus vaccine involved the complete cycle from basic research to product development of this advanced vaccine in India. 

  • This initiative is an example of India`s capabilities for high-end research and development; manufacture of sophisticated pharmaceutical products in India; and, effective Public-Private-Partnership model for finding affordable solutions to societal challenges. 

  • The development of the rotavirus vaccine would inspire higher levels of research, development and manufacturing activities in India. 

  • This vaccine is a successful example of collaboration between India and the United States in the area of medical research, for the benefit of ordinary citizens. 

  • The vaccine has been developed under partnership between the Ministry of Science and Technology, the institutions of the US Government, various government institutions and NGOs in India, supported by the Bill and Melinda Gates Foundation. 

  • Funding by Government of India supported basic research in educational and scientific institutions in India. This was also supplemented by the support of U.S. Government institutions like the National Institute of Health. 

  • The Gates Foundation and Bharat Biotech India Limited have contributed towards product development and testing. 

  • The successful launch of the first indigenously developed and produced vaccine was the result of an extraordinary effort spread over the last 25 years.

  • The Bharat Biotech India Limited that was involved in the development and production of the vaccine was selected in 1997-1998 by the India-U.S. Vaccine Action Programme and the standard government procedures. 

  • The company has been given undertaken to keep the cost of the vaccine at 1 dollar per dose. 

  • This is the third such vaccine available globally against Rotavirus and, at the current prices, the cheapest.


Helpline Number : 87501 87501
To Subscribe Newsletter and Get Updates.